https://cms.megaphone.fm/channel/NPTNI3439944925 en Copyright 2026 Inception Point AI Host Julia Cartwright investigates why GLP-1 drugs have become a game-changer for women over 40 struggling with perimenopausal weight gain. Each episode examines the science behind hormonal metabolism shifts, clinical trial results across reproductive stages, and critical safety concerns including bone density loss and muscle depletion. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI. https://megaphone.imgix.net/podcasts/a12644f6-4da3-11f1-b918-9b998bca321e/image/69b0fb9d62b31cc2ccca3e09be1258d7.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress https://cms.megaphone.fm/channel/NPTNI3439944925 no episodic Inception Point AI Host Julia Cartwright investigates why GLP-1 drugs have become a game-changer for women over 40 struggling with perimenopausal weight gain. Each episode examines the science behind hormonal metabolism shifts, clinical trial results across reproductive stages, and critical safety concerns including bone density loss and muscle depletion. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI. Quiet. Please info@inceptionpoint.ai https://player.megaphone.fm/NPTNI9452299729 Join host Julia Cartwright for an evidence-based deep dive into GLP-1 drugs and women over 40. Explore the real science behind midlife metabolism, what clinical trials reveal about these medications at every menopause stage, and the risks often left out. No hype, no judgment—just straight talk for informed health decisions. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. Tue, 07 Apr 2026 02:51:21 -0000 trailer Inception Point AI Join host Julia Cartwright for an evidence-based deep dive into GLP-1 drugs and women over 40. Explore the real science behind midlife metabolism, what clinical trials reveal about these medications at every menopause stage, and the risks often left out. No hype, no judgment—just straight talk for informed health decisions. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. 35 https://player.megaphone.fm/NPTNI3859750197 Join host Julia Cartwright as she covers the critical but often-overlooked risks of GLP-1 medications for women over forty, including bone density loss, muscle depletion, gallbladder complications, and weight regain after discontinuation. With empathy and evidence-based insight, Julia discusses what to monitor when hormonal changes and rapid weight loss collide. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. Tue, 07 Apr 2026 02:51:20 -0000 full Inception Point AI Join host Julia Cartwright as she covers the critical but often-overlooked risks of GLP-1 medications for women over forty, including bone density loss, muscle depletion, gallbladder complications, and weight regain after discontinuation. With empathy and evidence-based insight, Julia discusses what to monitor when hormonal changes and rapid weight loss collide. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. 1350 https://player.megaphone.fm/NPTNI5070743417 Host Julia Cartwright examines clinical trial data on GLP-1 drugs for women over 40, covering the SURMOUNT trials showing 20-26% weight loss across reproductive stages, waist circumference reductions, and findings that women may respond better than men. She discusses combining tirzepatide with hormone therapy and addresses midlife metabolic changes affecting this demographic. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. Tue, 07 Apr 2026 02:51:16 -0000 full Inception Point AI Host Julia Cartwright examines clinical trial data on GLP-1 drugs for women over 40, covering the SURMOUNT trials showing 20-26% weight loss across reproductive stages, waist circumference reductions, and findings that women may respond better than men. She discusses combining tirzepatide with hormone therapy and addresses midlife metabolic changes affecting this demographic. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. 1615 https://player.megaphone.fm/NPTNI5677032309 Julia Cartwright explores why women over 40 face stubborn weight gain as estrogen declines, examining how GLP-1 drugs like semaglutide and tirzepatide target the specific hormonal mechanisms behind midlife metabolism changes, visceral fat accumulation, and relentless food cravings—with clinical trial data showing significant results across all reproductive stages. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. Tue, 07 Apr 2026 02:51:10 -0000 full Inception Point AI Julia Cartwright explores why women over 40 face stubborn weight gain as estrogen declines, examining how GLP-1 drugs like semaglutide and tirzepatide target the specific hormonal mechanisms behind midlife metabolism changes, visceral fat accumulation, and relentless food cravings—with clinical trial data showing significant results across all reproductive stages. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI. 1504